Safety Shot, Inc. SHOT shares traded higher on Monday after the company announced it retained a law firm to investigate recent stock performance and a recent short report.
What To Know: The company announced on Monday that it retained attorney Mark R. Basile and his short and distort securities litigation firm, The Basile Law Firm P.C., to investigate recent developments concerning the company's stock performance. The legal team is prepared to take any necessary legal actions to deter potential market participants who may be employing illicit methods to inflict further harm on retail investors. The recently published research paper by Capybara Research is one of these concerns.
Brian S. John, CEO of Safety Shot, Inc., said "We are pleased to welcome Mr. Basile to our legal team. We are committed to legally pursue all short and distort campaigns against the company as well as all media outlets that irresponsibly reported the false, misleading and defaming Capybara Report."
"Mr. Basile understands how short and distort campaigns negatively affect retail shareholders and will be leading this and other litigation we plan to protect the company and its shareholders."
Related Link: What's Going On With Symbotic Stock?
SHOT Price Action: Shares of SHOT were up 29.5% at $4.70 at the close of the market, according to Benzinga Pro.
Image by Foundry Co from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.